Everglades Biopharma LLC
Everglades Biopharma LLC is a Houston-based company specializing in the development of ligand-based therapies. Their innovative proprietary technology, ligandomics, allows for the systematic identification of disease-specific cellular ligands as therapeutic targets, resulting in therapies with higher efficacy and fewer side effects.
With a focus on neovascular disease conditions, Everglades Biopharma is currently developing a therapeutic antibody that targets a novel angiogenic ligand upregulated in these conditions, offering potential treatments for neovascular age-related macular degeneration (AMD), diabetic macular edema, and cancer.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
